iNtrAcranial PreSsurE in Intensive Care (ICU) (SynapseICU) (SynapseICU)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03257904 |
Recruitment Status :
Completed
First Posted : August 22, 2017
Last Update Posted : July 7, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Intracranial pressure (ICP) monitoring is the most common neuromonitoring modality used in neurocritical care units (NCCU) around the world. Uncertainties remain around intracranial pressure monitoring both in traumatic and non-traumatic brain injury, and variation in clinical practice of intracranial pressure monitoring exists between neurocritical care units.
The objectives of the study will explore intracranial pressure monitoring variation in practice to prioritise uncertainties in the clinical management of critical care patients with acute brain injury and support further collaborative hypotheses-based prospective studies.
Condition or disease | Intervention/treatment |
---|---|
Traumatic Brain Injury Subarachnoid Hemorrhage Intracerebral Hemorrhage | Procedure: intracranial pressure monitoring |
Intracranial pressure (ICP) monitoring is the most common neuromonitoring modality used in neurocritical care units (NCCU) around the world. Uncertainties remain around intracranial pressure monitoring both in traumatic and non-traumatic brain injury, and variation in clinical practice of intracranial pressure monitoring exists between neurocritical care units.
The objectives of the study will explore intracranial pressure monitoring variation in practice to prioritise uncertainties in the clinical management of critical care patients with acute brain injury and support further collaborative hypotheses-based prospective studies.
Sample Size: This international prospective observational study aims to recruit >2000 patients in coma after acute traumatic and non-traumatic brain damage admitted to >200 Intensive Care Units.
Inclusion Criteria:
-
Acute brain injury (ABI) admitted to ICU following:
- Hemorrhagic stroke, including intracerebral hematoma and subarachnoid hemorrhage,
- Traumatic brain injury (penetrating and non-penetrating).
- Age >18 years old
- Glasgow Coma Score with Eyes response = 1 (no eyes opening) and Motor score ≤5 (not following commands) at the admission to ICU or neuro-worsening within the first 48 hours with no eye opening and the Motor score decreased to ≤5
Exclusion Criteria:
- ABI who are not admitted to ICU;
- ABI due to infections of the central nervous system, ischemic stroke or other causes not defined in the inclusion criteria
Outcome measures:
Glasgow Outcome Score-Extended at 6 months
Endpoint:
The primary endpoint is the variation in clinical practice around ICP monitoring in acute brain injury patients.
Screening and recruitment: 12 weeks at each centre, or the duration required to enrol 90 patients per centre.
Follow-up: outcome measures will be collected at 6 months.
Duration of study: 2 years.
The SYNAPSE-ICU study is partly funded by ESICM (ESICM Trials Group Portfolio).
Study Type : | Observational |
Actual Enrollment : | 2395 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | International Prospective Observational StudY on iNtrAcranial PreSsurE in Intensive Care (ICU) (SynapseICU) |
Actual Study Start Date : | March 15, 2018 |
Actual Primary Completion Date : | December 31, 2019 |
Actual Study Completion Date : | June 11, 2020 |

- Procedure: intracranial pressure monitoring
measurement of intracranial pressure
- Long-term outcome measures of neurological disability [ Time Frame: 6 months ]Extended Glasgow Outcome Scale score

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age > 18 years;
- Diagnosis of an acute brain injury (ABI) due to primary hemorrhagic stroke (including intracranial hemorrhage or subarachnoid hemorrhage) or traumatic brain injury;
- Glasgow Coma Score with Eyes response = 1 (no eyes opening) and Motor score ≤5 (not following commands) at the admission to ICU or neuro-worsening within the first 48 hours with no eye opening and the Motor score decreased to ≤5.
Exclusion Criteria:
- Acute Brain Injury (ABI) who are not admitted to ICU;
- ABI due to infections of the central nervous system, ischaemic stroke or other causes not defined in the inclusion criteria.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03257904
Italy | |
ASST-Monza | |
Monza, MB, Italy, 20900 |
Principal Investigator: | Giuseppe Citerio | University Milano Bicocca |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Giuseppe Citerio, MD, Professor, University of Milano Bicocca |
ClinicalTrials.gov Identifier: | NCT03257904 |
Other Study ID Numbers: |
SynapseICU |
First Posted: | August 22, 2017 Key Record Dates |
Last Update Posted: | July 7, 2020 |
Last Verified: | July 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
intracranial pressure |
Brain Injuries Brain Injuries, Traumatic Subarachnoid Hemorrhage Cerebral Hemorrhage Hemorrhage Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Craniocerebral Trauma Trauma, Nervous System Wounds and Injuries Pathologic Processes Intracranial Hemorrhages Cerebrovascular Disorders Vascular Diseases Cardiovascular Diseases |